ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 819,95
-0,39%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Pear Therapeutics Inc (PEAR)

  7. Pear Therapeutics Inc (PEAR) Actualités

PEAR

Pear Therapeutics (PEAR)

Pear Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PEAR
DateHeureSourceTitreSymboleSociété
02/05/202319h37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:PEARPear Therapeutics Inc
12/04/202322h34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PEARPear Therapeutics Inc
10/04/202322h37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PEARPear Therapeutics Inc
07/04/202317h30Business WirePear Therapeutics Files for Chapter 11 and Will Seek to Sell Assets Through Sales ProcessNASDAQ:PEARPear Therapeutics Inc
03/04/202322h05GlobeNewswire Inc.Sight Sciences Appoints Ali Bauerlein as Chief Financial OfficerNASDAQ:PEARPear Therapeutics Inc
31/03/202322h04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PEARPear Therapeutics Inc
17/03/202314h15Business WirePear Therapeutics Announces Process Exploring Strategic AlternativesNASDAQ:PEARPear Therapeutics Inc
27/02/202314h00Business WirePear Therapeutics to Participate in 43rd Annual Cowen Healthcare ConferenceNASDAQ:PEARPear Therapeutics Inc
09/02/202322h43Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PEARPear Therapeutics Inc
02/02/202314h00Business WirePear Therapeutics to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:PEARPear Therapeutics Inc
26/01/202314h00Business WirePear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use DisordersNASDAQ:PEARPear Therapeutics Inc
24/01/202322h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PEARPear Therapeutics Inc
18/01/202314h00Business WirePear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug ListNASDAQ:PEARPear Therapeutics Inc
17/01/202314h00Business WirePear Therapeutics to Participate in Citi’s BioTech C-Suite Virtual Fireside Chat SeriesNASDAQ:PEARPear Therapeutics Inc
12/01/202314h00Business WireCalifornia Department of Health Care Services Awards Contract to Pear Therapeutics to Support the Recovery Incentives ProgramNASDAQ:PEARPear Therapeutics Inc
10/01/202322h21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PEARPear Therapeutics Inc
10/01/202314h00Business WirePear Therapeutics and COEUS Healthcare Partner to Combat the Addiction Crisis With Prescription Digital TherapeuticsNASDAQ:PEARPear Therapeutics Inc
04/01/202322h21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PEARPear Therapeutics Inc
04/01/202314h00Business WirePear Therapeutics and Spero Health to Expand Access to Prescription Digital Therapeutics for People in Recovery Across Multiple Locations and StatesNASDAQ:PEARPear Therapeutics Inc
04/01/202312h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PEARPear Therapeutics Inc
03/01/202313h38Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PEARPear Therapeutics Inc
15/12/202214h00Business WirePear Therapeutics Presents Real-World Clinical Data Assessing Engagement and Abstinence in Patients with Alcohol Use Disorders Using reSET® at AAAPNASDAQ:PEARPear Therapeutics Inc
21/11/202214h00Business WirePear Therapeutics to Participate in Evercore ISI 5th Annual HealthCONx ConferenceNASDAQ:PEARPear Therapeutics Inc
15/11/202201h45TipRanksPear Therapeutics (PEAR) Receives a Buy from BTIGNASDAQ:PEARPear Therapeutics Inc
14/11/202223h53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PEARPear Therapeutics Inc
14/11/202222h02Business WirePear Therapeutics Reports Third Quarter 2022 ResultsNASDAQ:PEARPear Therapeutics Inc
10/11/202214h00Business WirePear Therapeutics to Participate in the BTIG Digital Health ForumNASDAQ:PEARPear Therapeutics Inc
07/11/202214h00Business WirePear Therapeutics Presents Real-World Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® at ISPOR EuropeNASDAQ:PEARPear Therapeutics Inc
03/11/202213h00Business WireState of Wisconsin to Provide Access to Prescription Digital Therapeutics to Help Local Communities Fight Against Addiction CrisisNASDAQ:PEARPear Therapeutics Inc
01/11/202221h02Business WirePear Therapeutics to Participate in the Credit Suisse 31st Annual Healthcare ConferenceNASDAQ:PEARPear Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PEAR

Dernières Valeurs Consultées

EU
EKLDC
BNP Paribas Easy MSCI US...
DBI
I1NM
XMWMVEUE1CCHFINAV
BIT
UC8HWV
Unicredit Bank
NASDAQ
SGLB
Sigma Labs
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés